💊
Yartemlea
Narsoplimab
Thrombotic Microangiopathies;Hematopoietic Stem Cell Transplantation
ℹ️ Opinion under re-examination
✅
Ingen aktive alarmer
Denne medicin har ingen igangværende mangel, sikkerhedsbreve eller tilbagekaldelser.
Hvad det bruges til
Treatment of patients with haemopoietic stem cell transplant-associated thrombotic microangiopathy
⚠️ Patient sikkerhed
No
Officiel EMA-side
https://www.ema.europa.eu/en/medicines/human/EPAR/yartemlea